Labcorp Holdings Inc. (LH)
LHNYSEMedical Specialities
$371.86
+0.0300 (+0.01%) today
Regular session, Nov 10, 2:05 PM ET
- Market cap
- $30.20bn
- P/E
- 20.6
- EPS, last 4 quarters
- $18.09
- Dividend yield
- –
- Day range
- $363.19 to $372.43
- 52-week range
- $245.00 to $373.76
- Average volume
- 764.8k
- Previous close
- $371.83
Analysts
13 coveringBuy10 buy, 3 hold, 0 sell
Targets a year out average $387.18, +4.1% from here
Earnings
next estimate $4.50Next report
Dec 2025
+3.0%
Mar 2026
+3.9%
Jun 2026
+4.2%
Sep 2026
+2.8%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $3.52bn | $3.54bn | $3.73bn | $3.81bn |
| Gross profit | $993.20m | $1.01bn | $1.11bn | $1.11bn |
| Operating income | $267.60m | $380.80m | $451.60m | $402.10m |
| Net income | $164.70m | $277.80m | $298.70m | $262.80m |
Last four quarters: revenue $14.59bn, margin 6.9%, free cash flow $1.29bn
News
8 latest- Labcorp Holdings (LH) is a Top-Ranked Momentum Stock: Should You Buy?Zacks · 5 days ago
- Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?Zacks · Oct 30, 2026
- Labcorp (LH) Q3 2026 Earnings Call TranscriptThe Motley Fool · Oct 28, 2026
- Labcorp Q3 Earnings Call HighlightsMarketBeat · Oct 28, 2026
- Wednesday Sector Leaders: Music & Electronics Stores, Diagnostics BNK Invest · Oct 28, 2026
- Labcorp Holdings Inc. Reports Third Quarter 2026 Results and Raises Full Year GuidanceFintel · Oct 28, 2026
- LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View Up Zacks · Oct 28, 2026
- Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key MetricsZacks · Oct 28, 2026
The company
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025, and performed more than 750 million tests for patients around the world.
- Sector
- Health Care
- Industry
- Medical Specialities
- Exchange
- NYSE
- Region
- North America
- Website
- labcorp.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.